Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adults
Quinn S. Wells, Olivia J. Veatch, Joshua P. Fessel, et al.
Pharmacogenetics and Genomics (2017) Vol. 27, Iss. 7, pp. 247-254
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy
Pablo García‐Pavía, Yuri Kim, Maria Alejandra Restrepo‐Córdoba, et al.
Circulation (2019) Vol. 140, Iss. 1, pp. 31-41
Open Access | Times Cited: 278
The Role of Biomarkers in Cardio-Oncology
Kajaluxy Ananthan, Alexander R. Lyon
Journal of Cardiovascular Translational Research (2020) Vol. 13, Iss. 3, pp. 431-450
Open Access | Times Cited: 133
Preventing and Treating Anthracycline Cardiotoxicity: New Insights
Konrad Teodor Sawicki, Valentina Sala, Lorenzo Prever, et al.
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 309-332
Closed Access | Times Cited: 131
Biomarkers in heart failure: the past, current and future
Sarhene Michael, Yili Wang, Jing Wei, et al.
Heart Failure Reviews (2019) Vol. 24, Iss. 6, pp. 867-903
Closed Access | Times Cited: 107
Functional Validation of Doxorubicin-Induced Cardiotoxicity-Related Genes
Hananeh Fonoudi, Mariam Jouni, Romina B. Cejas, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 1, pp. 38-50
Open Access | Times Cited: 14
Chemotherapy-Related Cardiac Dysfunction
Marijke Linschoten, Arco J. Teske, Maarten J. Cramer, et al.
Circulation Genomic and Precision Medicine (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 78
Genetics of Anthracycline Cardiomyopathy in Cancer Survivors
Smita Bhatia
JACC CardioOncology (2020) Vol. 2, Iss. 4, pp. 539-552
Open Access | Times Cited: 66
Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and Beyond
Umberto Attanasio, Elena Di Sarro, Lucia Tricarico, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 199-199
Open Access | Times Cited: 6
Anthracycline Toxicity: Light at the End of the Tunnel?
Romina B. Cejas, Kateryna Petrykey, Yadav Sapkota, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 115-134
Open Access | Times Cited: 15
The Influence of Big (Clinical) Data and Genomics on Precision Medicine and Drug Development
Joshua C. Denny, Sara L. Van Driest, Wei‐Qi Wei, et al.
Clinical Pharmacology & Therapeutics (2017) Vol. 103, Iss. 3, pp. 409-418
Open Access | Times Cited: 48
Genome‐wide and Phenome‐wide Approaches to Understand Variable Drug Actions in Electronic Health Records
Jamie R. Robinson, Joshua C. Denny, Dan M. Roden, et al.
Clinical and Translational Science (2017) Vol. 11, Iss. 2, pp. 112-122
Open Access | Times Cited: 43
Defining Phenotypes from Clinical Data to Drive Genomic Research
Jamie R. Robinson, Wei‐Qi Wei, Dan M. Roden, et al.
Annual Review of Biomedical Data Science (2018) Vol. 1, Iss. 1, pp. 69-92
Open Access | Times Cited: 41
Accelerating Biomarker Discovery Through Electronic Health Records, Automated Biobanking, and Proteomics
Quinn S. Wells, Deepak K. Gupta, J. G. Smith, et al.
Journal of the American College of Cardiology (2019) Vol. 73, Iss. 17, pp. 2195-2205
Open Access | Times Cited: 41
Machine Learning Identifies Clinical and Genetic Factors Associated With Anthracycline Cardiotoxicity in Pediatric Cancer Survivors
Marie Chaix, Neha Parmar, Caroline Kinnear, et al.
JACC CardioOncology (2020) Vol. 2, Iss. 5, pp. 690-706
Open Access | Times Cited: 34
Clinical Trial in a Dish
Chi Keung Lam, Joseph C. Wu
Arteriosclerosis Thrombosis and Vascular Biology (2021) Vol. 41, Iss. 3, pp. 1019-1031
Open Access | Times Cited: 30
Precision Cardio-Oncology
Alexandra Dreyfuss, Paco E. Bravo, Constantinos Koumenis, et al.
Journal of Nuclear Medicine (2019) Vol. 60, Iss. 4, pp. 443-450
Open Access | Times Cited: 35
Variants in structural cardiac genes in patients with cancer therapy-related cardiac dysfunction after anthracycline chemotherapy: a case control study
Hanne M. Boen, Maaike Alaerts, Inge Goovaerts, et al.
Cardio-Oncology (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 3
PGxO and PGxLOD: a reconciliation of pharmacogenomic knowledge of various provenances, enabling further comparison
Pierre Monnin, Joël Legrand, Graziella Husson, et al.
BMC Bioinformatics (2019) Vol. 20, Iss. S4
Open Access | Times Cited: 29
Cardioprotection in cancer therapy: novel insights with anthracyclines
Inbar Raber, Aarti Asnani
Cardiovascular Research (2019) Vol. 115, Iss. 5, pp. 915-921
Closed Access | Times Cited: 27
Common genetic predisposition for heart failure and cancer
Tobias J. Pfeffer, Stefan Pietzsch, Denise Hilfiker‐Kleiner
Herz (2020) Vol. 45, Iss. 7, pp. 632-636
Open Access | Times Cited: 26
Future Perspectives of Cardiovascular Biomarker Utilization in Cancer Survivors: A Scientific Statement From the American Heart Association
Vlad G. Zaha, Salim S. Hayek, Kevin Alexander, et al.
Circulation (2021) Vol. 144, Iss. 25
Open Access | Times Cited: 21
The Roles of Histone Lysine Methyltransferases in Heart Development and Disease
Jun‐yi Zhu, Joyce van de Leemput, Zhe Han
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 7, pp. 305-305
Open Access | Times Cited: 8
hiPSCs in cardio-oncology: deciphering the genomics
Emily Pinheiro, K. Ashley Fetterman, Paul W. Burridge
Cardiovascular Research (2019) Vol. 115, Iss. 5, pp. 935-948
Open Access | Times Cited: 24
Possible Susceptibility Genes for Intervention against Chemotherapy-Induced Cardiotoxicity
Xinyu Yang, Guoping Li, Tao Yang, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-30
Open Access | Times Cited: 22
Second Hits in Dilated Cardiomyopathy
Peter Marstrand, Kermshlise Picard, Neal K. Lakdawala
Current Cardiology Reports (2020) Vol. 22, Iss. 2
Closed Access | Times Cited: 21
Page 1 - Next Page

Scroll to top